Patent details

EP1541554 Title: CRYSTAL FOR ORAL SOLID DRUG AND ORAL SOLID DRUG FOR DYSURIA TREATMENT CONTAINING THE SAME

Basic Information

Publication number:
EP1541554
PCT Application Number:
PCT/JP/2003/011345
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP037942497
PCT Publication Number:
WO/2004/022538
First applicant's nationality:
Translation Language:
EPO Publication Language:
Not available
English Title of Invention:
CRYSTAL FOR ORAL SOLID DRUG AND ORAL SOLID DRUG FOR DYSURIA TREATMENT CONTAINING THE SAME
French Title of Invention:
CRISTAL POUR MEDICAMENT SOLIDE A ADMINISTRATION ORALE ET MEDICAMENT SOLIDE A ADMINISTRATION ORALE DESTINE AU TRAITEMENT DE LA DYSURIE CONTENANT CE CRISTAL
German Title of Invention:
KRISTALL FÜR EIN ORALES, FESTES ARZNEIMITTEL, UND EIN ORALES, FESTES ARNZEIMITTEL ZUR BEHANDLUNG VON DYSURIE, DAS DIESEN ENTHÄLT
SPC Number:

Dates

Filing date:
05/09/2003
Grant date:
03/12/2008
EP Publication Date:
03/12/2008
PCT Publication Date:
18/03/2004
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/06/2005
EP B1 Publication Date:
03/12/2008
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/09/2009
Expiration date:
05/09/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/09/2003
 
 

Name:
Kissei Pharmaceutical Co. Ltd.
Address:
19-48, Yoshino, Matsumoto-City Nagano-Pref. 399-8710, Japan (JP)

Inventor

1

Name:
HIRATA Kazuma, c/o Central Research Laboratories
Address:
Japan (JP)

2

Name:
TSURU Eiji, c/o Central Res. Laboratories
Address:
Japan (JP)

3

Name:
TODA Michio, c/o Central Research Laboratories
Address:
Japan (JP)

Priority

Priority Number:
2002262157
Priority Date:
06/09/2002
Priority Country:
Japan (JP)

Classification

Main IPC Class:
C07D 209/08;
Filing date Document type Number of pages